This is a Firm Fixed Price BPA Call contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $113,618.48, is for the supply of HPV testing equipment, supplies, and maintenance services for the second option year. The contract is not set-aside. Roche Diagnostics has previously received awards from the VA, Department of Defense,...
This is a $77,704.92 Firm Fixed Price BPA Call contract awarded by the Veterans Integrated Service Network 10 of the Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide HPV testing equipment, supplies, and preventative maintenance through the critical analyzers, laboratory equipment GSA Schedule contract. The award has no set-aside designation. Roche Diagnostics provides a variety of medical devices, reagents, and laboratory...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) call order worth $299,999.03 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide reagents and consumables for HPV/CT/NG testing. This award is under Roche's existing GSA Schedule contract for critical laboratory analyzers and supplies. Roche, a foreign-owned manufacturer of in vitro diagnostics and medical devices, has a long history of providing equipment, reagents, and...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a Blanket Purchase Agreement (BPA) call placed by the U.S. Department of Veterans Affairs (VA) for HPV testing equipment, supplies, and preventative maintenance option year 3. The award ceiling value is $84,142.60 and the contract is a Firm Fixed Price arrangement under the VA's Critical Analyzers, Laboratory Master Contract (FSS-66-III) on the General Services Administration (GSA)...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of a Roche HPV/HIV analyzer and related test kits, with a ceiling value of $64,386.51 and a performance period through December 17, 2023. The award was not set aside for any...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation. The contract, valued at $170,904.26, is for the delivery of reagents and consumables for HPV/CT/NG testing to support the VA's medical facilities. The contract was awarded through the VA's Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule contract. As the prime contractor, Roche Diagnostics provides in vitro diagnostics, reagents, laboratory...
This is a Blanket Purchase Agreement (BPA) call contract awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing, with a total...
This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2, is for HPV detection cost-per-test services during the option year 1 period. The contract has a ceiling value of $105,293.00 and is a firm fixed price Blanket Purchase Agreement (BPA) call order. The...
This is a Firm Fixed Price BPA Call awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, valued at $109,715.20. The contract is for the supply of reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing. This award is under Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers and Laboratory equipment. Roche Diagnostics is a global...
This is a BPA call order awarded to Roche Diagnostics Corporation by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs. The order is for reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing, to be delivered by September 30, 2023. The firm fixed-price contract has a ceiling value of $148,979.86 and is placed against Roche's General Services Administration (GSA) Schedule contract. There is no set-aside...